Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
Sedat Yilmaz, Ismail Simsek Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey Abstract: Tocilizumab is a fully humanized monoclonal antibody against interleukin-6 receptors that was approved for the treatment of patients with rheumatoid arthritis (RA). Several lines of evidence, o...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Dove Medical Press
2013-10-01
|
| سلاسل: | Therapeutics and Clinical Risk Management |
| الوصول للمادة أونلاين: | http://www.dovepress.com/early-intervention-in-the-treatment-of-rheumatoid-arthritis-focus-on-t-a14796 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|